Clinical trials
Withdrawn Hepatitis C trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
31 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2008 | 3 |
| 2009 | 2 |
| 2011 | 2 |
| 2012 | 2 |
| 2013 | 3 |
| 2014 | 3 |
| 2015 | 3 |
| 2018 | 3 |
| 2019 | 3 |
| 2020 | 2 |
| 2021 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Withdrawn | 31 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Massachusetts General Hospital | 4 |
| Bristol-Myers Squibb | 3 |
| National Institute of Allergy and Infectious Diseases (NIAID) | 2 |
| Raymond T. Chung, MD | 2 |
| University of Maryland, Baltimore | 2 |
| Avera McKennan Hospital & University Health Center | 1 |
| Cardiox Corporation | 1 |
| Henry Ford Health System | 1 |
| Kaiser Permanente | 1 |
| Stanford University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hepatitis C | 31 |
| Hepatitis C, Chronic | 4 |
| Carcinoma, Hepatocellular | 2 |
| Needlestick Injuries | 2 |
| Renal Insufficiency | 2 |
| Acidosis, Lactic | 1 |
| Fibrosis | 1 |
| HIV Infections | 1 |
| Hepatitis | 1 |
| Hepatitis B | 1 |
Trials
Showing 1 to 25 of 31. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.